Financial Contrast: T Stamp (NASDAQ:IDAI) versus Clarivate (NYSE:CLVT)

T Stamp (NASDAQ:IDAI) and Clarivate (NYSE:CLVT) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings.

Analyst Ratings

This is a summary of current ratings and recommmendations for T Stamp and Clarivate, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
T Stamp	0	0	0	0	0.00
Clarivate	1	3	0	0	1.75

Clarivate has a consensus target price of $4.8333, suggesting a potential upside of 13.46%. Given Clarivate’s stronger consensus rating and higher probable upside, analysts plainly believe Clarivate is more favorable than T Stamp.

Profitability

This table compares T Stamp and Clarivate’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
T Stamp	-330.16%	-289.85%	-130.19%
Clarivate	-17.33%	8.65%	3.85%

Valuation and Earnings

This table compares T Stamp and Clarivate”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
T Stamp	$3.08 million	2.33	-$10.60 million	($13.49)	-0.21
Clarivate	$2.56 billion	1.12	-$636.70 million	($0.62)	-6.87

T Stamp has higher earnings, but lower revenue than Clarivate. Clarivate is trading at a lower price-to-earnings ratio than T Stamp, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

T Stamp has a beta of 0.61, suggesting that its share price is 39% less volatile than the S&P 500. Comparatively, Clarivate has a beta of 1.4, suggesting that its share price is 40% more volatile than the S&P 500.

Institutional & Insider Ownership

16.3% of T Stamp shares are held by institutional investors. Comparatively, 85.7% of Clarivate shares are held by institutional investors. 1.7% of T Stamp shares are held by insiders. Comparatively, 23.2% of Clarivate shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Clarivate beats T Stamp on 10 of the 13 factors compared between the two stocks.

About T Stamp

T Stamp Inc. develops and markets identity authentication software solutions for government and enterprise partners, and peer-to-peer markets worldwide. It develops proprietary artificial intelligence-powered solutions, researching and leveraging machine learning, artificial intelligence, biometric science, cryptography, and data mining to deliver insightful identity and trust predictions that identify and defend against fraudulent identity attacks, protect sensitive user information, and extend the reach of digital services through global accessibility. It uses the Irreversibly Transformed Identity Token technology combined with a data architecture that can use one or multiple sources of biometric or other identifying data. The company also offers solutions for privacy and data protection, biometric multi-factor authentication, document validation, identity verification, geolocation, duplicate detection, age estimation, and biometric capture, as well as crypto security and compliance, and trusted message. It serves banking/fintech; humanitarian and development services; cryptocurrency and digital assets; biometrically secured email and digital communication; KYC/AML compliance; government and law enforcement; P2P transactions, social media, and sharing economy; and real estate, travel, and healthcare industries. T Stamp Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

About Clarivate

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.